The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMRN, FB and NVAX

NEW YORK, NY / ACCESSWIRE / November 18, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Amarin Corporation Plc (NASDAQ:AMRN)
Class Period: December 5, 2018 - June 21, 2021
Lead Plaintiff Deadline: December 23, 2021

During the class period, Amarin Corporation Plc allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) there was an increasingly high risk that certain of Amarin's patents would be invalidated; (ii) once the District Court invalidated certain of Amarin's patents, there was little to no chance of reversing that ruling; (iii) the Company's litigation was preventing it from effectuating a successful takeover; (iv) Defendants were downplaying the true threat the ongoing abbreviated new drug application litigation posed to the Company's business and future prospects; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in AMRN: https://www.kleinstocklaw.com/pslra-1/amarin-corporation-plc-loss-submission-form?id=21378&from=1

Meta Platforms, Inc. f.k.a. Facebook, Inc. (NASDAQ:FB)
Class Period: November 3, 2016 - October 21, 2021
Lead Plaintiff Deadline: December 27, 2021

The FB lawsuit alleges that throughout the class period, Meta Platforms, Inc. f.k.a. Facebook, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Facebook misrepresented its user growth; (2) Facebook knew, or should have known, that duplicate accounts represented a greater portion of its growth than stated, and it should have provided more detailed disclosures as to the implication of duplicate accounts to Facebook's user base and growth; (3) Facebook did not provide a fair platform for speech, and regularly protected high profile users via its Cross Check/XCheck system; (4) despite being aware of their use of Facebook's platforms, the Company failed to respond meaningfully to drug cartels, human traffickers, and violent organizations; (5) Facebook has been working to attract preteens to its platform and services; and (6) as a result, Defendants' public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in FB: https://www.kleinstocklaw.com/pslra-1/facebook-inc-loss-submission-form?id=21378&from=1

Novavax, Inc. (NASDAQ:NVAX)
Class Period: March 2, 2021 - October 19, 2021
Lead Plaintiff Deadline: January 11, 2022

The complaint alleges that throughout the class period Novavax, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Novavax overstated its manufacturing capabilities and downplayed manufacturing issues that would impact its approval timeline for NVX-CoV2373, a protein-based vaccine candidate engineered from the genetic sequence of the first strain of the SARS-CoV-2 coronavirus; (ii) as a result, Novavax was unlikely to meet its anticipated Emergency Use Authorization regulatory timelines for NVX-CoV2373; (iii) accordingly, the Company overstated the regulatory and commercial prospects for NVX-CoV2373; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in NVAX: https://www.kleinstocklaw.com/pslra-1/novavax-inc-loss-submission-form-2?id=21378&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

View source version on accesswire.com:
https://www.accesswire.com/673710/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-AMRN-FB-and-NVAX